doi:10.1097/MBC.0b013e32832ca31f Moll S, Ortel TL
Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period
Without that context, the FDA warning reads like a death sentence
doi: 10.1111/dom.15869 79 MouhammadZAVohraRHorwitzATheinARoveltJCvenkelBet al

In a rat forced-swimming model of mild organophosphorus intoxication, Meldonium (60 mg/kg) produced a smooth, sustained increase in endurance and maximal swimming time, but was less effective than hypoxen and octodrine, and combined administration did not show synergistic effects ( Metabolic modulators and clinical applications Meldonium is often grouped with metabolic modulators/antihypoxic agents that optimize energy utilization by shifting substrate selection and improving efficiency, including inhibitors of fatty-acid -oxidation (e.g., trimetazidine, ranolazine), succinate-based drugs (Mexidol, Cytoflavin), respiratory-chain components (cytochrome C, ubiquinone), and artificial redox systems (Hypoxen) ( Sports and regulatory context Because Meldonium shifts substrate utilization from fatty-acid oxidation toward carbohydrate metabolism, it was first placed under monitoring and then, in 2016, added to the World Anti-Doping Agency Prohibited List under S.4 Hormone and Metabolic Modulators
